Navigation Links
DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference Call
Date:2/24/2011

CUPERTINO, Calif., Feb. 24, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Wednesday, March 2, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

(Logo:  http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."  If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR™ (SABER™-Bupivacaine) and Amendment of the Nycomed Agreement
2. DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
3. DURECT to Present at the BIO CEO & Investor Conference
4. DURECT to Present at the Credit Suisse 2010 Healthcare Conference
5. DURECT Corporation Announces Third Quarter 2010 Financial Results
6. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
7. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
8. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
9. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
10. DURECT to Present at the Jefferies Global Life Sciences Conference
11. DURECT to Present at the Rodman & Renshaw Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... and PUNE, India , January ... published by Allied Market Research, titled, "Cold Chain Logistics ... Confectionary, Dairy & Frozen Dessert, Meat, Fish & Sea ... Analysis and Industry Forecasts, 2014-2022," projects that the global ... million by 2022, growing at a CAGR of 16% ...
(Date:1/24/2017)... , Jan. 24, 2017 Regeneron Pharmaceuticals, ... the Public today recognized 40 finalists in the Regeneron ... science and math competition for high school seniors. Finalists ... potential of their research projects. The finalists ... from March 9-15 to undergo a rigorous judging ...
(Date:1/24/2017)... -- Research and Markets has announced the addition of ... Material - Forecast to 2025" report to their offering. ... The Global Implantable ... around 5.4% over the next decade to reach approximately $54.28 billion ... market is witnessing include 3D medical printing is expected to develop ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... The Cradle to ... Agency (EPA) in its new recommendations of standards and ecolabels for ... announced. , Cradle to Cradle Certified is recommended at the highest level across ...
(Date:1/24/2017)... ... January 24, 2017 , ... In comments submitted ... (PCORI) for developing a data access and sharing policy. The nation’s leading biomedical ... plan as part of award applications, and earmarking specified amounts of grant funding ...
(Date:1/24/2017)... ... January 24, 2017 , ... i2i Population Health, a national leader in population ... , “Cary’s broad financial background is an excellent fit for i2i,” says Justin ... financial operations skills we need to take the company to the next level of ...
(Date:1/24/2017)... ... 24, 2017 , ... Seceon , the only threat ... today announced a strategic partnership with Paramount , the Middle East’s regional ... their critical information assets and infrastructure, in a comprehensive and cost effective manner. ...
(Date:1/24/2017)... ... 2017 , ... Center for Hispanic Leadership (CHL) Academy , the talent ... Manager, Employee & Labor Relations at City of Hope , a world-renowned independent ... Month. City of Hope is committed to stay out in front of its communities’ ...
Breaking Medicine News(10 mins):